Bellring Brands, Inc.
BRBR NYSE Food And Kindred Products Financials FY2018βFY2025
What Bellring Brands, Inc. does
No business description yet.
- Legal name
- BELLRING BRANDS, INC.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K Β· Nov 18, 2025
- Accession Β· CIK
- 0001772016-25-000153
0001772016
Revenue and margins
Bellring Brands, Inc. had $2.3B of revenue in fiscal 2025, up 16.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $256M in fiscal 2025, 11.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Bellring Brands, Inc. returned β to shareholders in fiscal 2025. The diluted share count fell 2.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Bellring Brands, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $153M | $35.8M | $48.4M | $70.8M | $71.8M |
| Debt incl. finance leases | $481M | $930M | $857M | $833M | $1.1B |
| Net debt / EBITDA | 1.5x | 3.8x | 2.6x | 1.8x | 2.7x |
| Interest coverage | 3.9x | 4.3x | 4.3x | 6.7x | 5.2x |
| Current ratio | 1.5x | 2.9x | 2.8x | 2.9x | 2.4x |
| Quick ratio | 1.1x | 1.5x | 1.5x | 1.5x | 1.2x |
| Total assets | $697M | $707M | $692M | $837M | $941M |
| Total liabilities | $762M | $1.1B | $1.0B | $1.0B | $1.4B |
| Shareholders' equity | β$3.1B | β$376M | β$324M | β$206M | β$454M |
| Net debt (β = net cash) | $329M | $894M | $808M | $762M | $1.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 9 | 6 / 9 | 5 / 9 | 7 / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | β | β16.5% | β11.8% | β29.4% | 8.7% | β7.2% | 6.1% | β5.0% |
| Altman Z'' | β | 7.96 | β10.62 | β15.63 | 2.59 | 4.16 | 6.17 | 5.82 |
8 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $828M | $854M | $988M | $1.2B | $1.4B | $1.7B | $2.0B | $2.3B |
| Gross profit | $278M | $312M | $338M | $386M | $422M | $530M | $707M | $770M |
| Research and development | $8.1M | $7.6M | $9.4M | $11.2M | $11.4M | $12.0M | $14.3M | $16.0M |
| Operating income | $120M | $163M | $164M | $168M | $212M | $287M | $388M | $357M |
| Interest expense | $0.0M | $0.0M | $54.7M | $43.2M | $49.2M | $66.9M | $58.3M | $68.4M |
| Pretax income | $120M | $163M | $109M | $123M | $146M | $220M | $329M | $289M |
| Income tax | $23.7M | $39.4M | $9.2M | $8.8M | $29.6M | $54.9M | $82.9M | $72.8M |
| Net income | $0.0M | $0.0M | $23.5M | $27.6M | $82.3M | $166M | $247M | $216M |
| Diluted EPS | $0.00 | $0.00 | $0.60 | $0.70 | $0.88 | $1.23 | $1.86 | $1.68 |
| Diluted shares | 0.00B | 0.00B | 0.04B | 0.04B | 0.09B | 0.13B | 0.13B | 0.13B |
| Cash flow | ||||||||
| Cash from operations | $141M | $98.3M | $97.2M | $226M | $21.0M | $216M | $200M | $261M |
| Capital expenditure | $5.0M | $3.2M | $2.1M | $1.6M | $1.8M | $1.8M | $1.8M | $4.7M |
| Free cash flow | $136M | $95.1M | $95.1M | $225M | $19.2M | $214M | $198M | $256M |
| Depreciation and amortization | $25.9M | $25.3M | $25.3M | $53.7M | $21.3M | $28.3M | $36.5M | $18.6M |
| Stock-based compensation | $0.0M | $0.0M | $2.5M | $4.6M | $9.8M | $14.2M | $21.0M | $22.1M |
| Share buybacks | β | β | $0.0M | $0.0M | $42.8M | β | β | β |
| Dividends and buybacks | β | β | $0.0M | $0.0M | $42.8M | β | β | β |
| Balance sheet | ||||||||
| Cash and short-term investments | $10.9M | $5.5M | $48.7M | $153M | $35.8M | $48.4M | $70.8M | $71.8M |
| Total debt | β | $0.0M | $623M | $481M | $930M | $857M | $833M | $1.1B |
| Current assets | β | $220M | $290M | $388M | $421M | $424M | $593M | $666M |
| Current liabilities | β | $92.7M | $153M | $251M | $144M | $150M | $204M | $283M |
| Inventory | β | $138M | $151M | $118M | $200M | $194M | $286M | $330M |
| Property and equipment, net | β | $11.7M | $10.2M | $8.9M | $8.0M | $8.5M | $9.2M | $19.0M |
| Goodwill | β | $65.9M | $65.9M | $65.9M | $65.9M | $65.9M | $65.9M | $65.9M |
| Intangible assets | β | $297M | $274M | $223M | $203M | $177M | $142M | $125M |
| Total assets | β | $595M | $654M | $697M | $707M | $692M | $837M | $941M |
| Total liabilities | β | $108M | $815M | $762M | $1.1B | $1.0B | $1.0B | $1.4B |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $452M | $486M | β$2.2B | β$3.1B | β$376M | β$324M | β$206M | β$454M |
| Margins | ||||||||
| Gross margin | 33.6% | 36.5% | 34.2% | 31.0% | 30.8% | 31.8% | 35.4% | 33.3% |
| Operating margin | 14.5% | 19.0% | 16.6% | 13.5% | 15.5% | 17.2% | 19.4% | 15.4% |
| EBITDA margin | 17.6% | 22.0% | 19.2% | 17.8% | 17.0% | 18.9% | 21.3% | 16.2% |
| Net margin | 0.0% | 0.0% | 2.4% | 2.2% | 6.0% | 9.9% | 12.3% | 9.3% |
| FCF margin | 16.5% | 11.1% | 9.6% | 18.0% | 1.4% | 12.8% | 9.9% | 11.0% |
| Returns | ||||||||
| Return on capital | β | 25.6% | β | β | 32.7% | 44.5% | 52.1% | 47.9% |
| Return on capital employed | β | 32.4% | 32.8% | 37.7% | 37.7% | 53.1% | 61.2% | 54.3% |
| Return on equity | 0.0% | 0.0% | β | β | β | β | β | β |
| Return on assets | β | 0.0% | 3.8% | 4.1% | 11.7% | 23.7% | 32.3% | 24.3% |
| Return on tangible equity | 0.0% | 0.0% | β | β | β | β | β | β |
| Growth | ||||||||
| Revenue growth | β | 3.3% | 15.7% | 26.2% | 10.0% | 21.5% | 19.8% | 16.1% |
| Net income growth | β | β | β | 17.4% | 198.2% | 101.1% | 48.9% | β12.3% |
| EPS growth | β | β | β | 16.7% | 25.7% | 39.8% | 51.2% | β9.7% |
| FCF growth | β | β30.2% | 0.0% | 136.1% | β91.4% | 1,013.5% | β7.5% | 29.4% |
| Share count change | β | β | β | 0.5% | 136.3% | 43.0% | β1.3% | β2.9% |
| Financial health | ||||||||
| Net debt / EBITDA | β | β0.0x | 3.0x | 1.5x | 3.8x | 2.6x | 1.8x | 2.7x |
| Debt / equity | β | 0.0x | β | β | β | β | β | β |
| Interest coverage | β | β | 3.0x | 3.9x | 4.3x | 4.3x | 6.7x | 5.2x |
| Current ratio | β | 2.4x | 1.9x | 1.5x | 2.9x | 2.8x | 2.9x | 2.4x |
| Quick ratio | β | 0.9x | 0.9x | 1.1x | 1.5x | 1.5x | 1.5x | 1.2x |
| Capital allocation | ||||||||
| Capex / revenue | 0.6% | 0.4% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% |
| Stock comp / revenue | 0.0% | 0.0% | 0.3% | 0.4% | 0.7% | 0.9% | 1.1% | 1.0% |
| Payouts / FCF | β | β | 0.0% | 0.0% | 222.9% | β | β | β |
| Quality scores | ||||||||
| Piotroski F-score | β | β | 5.0 | 6.0 | 5.0 | 7.0 | 7.0 | 5.0 |
| Altman Z'' | β | 8.0 | β10.6 | β15.6 | 2.6 | 4.2 | 6.2 | 5.8 |
| Accruals ratio | β | β16.5% | β11.8% | β29.4% | 8.7% | β7.2% | 6.1% | β5.0% |
Source: SEC EDGAR XBRL filings (CIK 0001772016). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.